As of June 6, 2022, the novel coronavirus SARS-CoV-2 that originated in Wuhan, the capital of Hubei province in China, had infected over 2.1 million people and killed 14,612 in the country. Hong Kong is currently the region with the highest active cases in China.

From Wuhan to the rest of China

In late December 2019, health authorities in Wuhan detected several pneumonia cases of unknown cause. Most of these patients had links to the Huanan Seafood Market. With Chinese New Year approaching, millions of Chinese migrant workers travelled back to their hometowns for the celebration. Before the start of the travel ban on January 23, around five million people had left Wuhan. By the end of January, the number of infections had surged to over ten thousand. The death toll from the virus exceeded that of the SARS outbreak a few days later. On February 12, thousands more cases were confirmed in Wuhan after an improvement to the diagnosis method, resulting in another sudden surge of confirmed cases. On March 31, 2020, the National Health Commission (NHC) in China announced that it would begin reporting the infection number of symptom-free individuals who tested positive for coronavirus. On April 17, 2020, health authorities in Wuhan revised its death toll, adding 50 percent more fatalities. After quarantine measures were implemented, the country reported no new local coronavirus COVID-19 transmissions for the first time on March 18, 2020.

The overloaded healthcare system

In Wuhan, 28 hospitals were designated to treat coronavirus patients, but the outbreak continued to test China’s disease control system and most of the hospitals were soon fully occupied. To combat the virus, the government announced plans to build a new hospital swiftly. On February 3, 2020, Huoshenshan Hospital was opened to provide an additional 1,300 beds. Due to an extreme shortage of health-care professionals in Wuhan, thousands of medical staff from all over China came voluntarily to the epicenter to offer their support. After no new deaths reported for first time, China lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country.

COVID-19: Number of Death: Year to Date: Hubei: Wuhan data was reported at 3,869.000 Person in 13 Dec 2022. This stayed constant from the previous number of 3,869.000 Person for 12 Dec 2022. COVID-19: Number of Death: Year to Date: Hubei: Wuhan data is updated daily, averaging 3,869.000 Person from Jan 2020 (Median) to 13 Dec 2022, with 1069 observations. The data reached an all-time high of 3,869.000 Person in 13 Dec 2022 and a record low of 1.000 Person in 14 Jan 2020. COVID-19: Number of Death: Year to Date: Hubei: Wuhan data remains active status in CEIC and is reported by National Health Commission. The data is categorized under High Frequency Database’s Disease Outbreaks – Table CN.GZ: COVID-19: No of Death. Clinical diagnosis included in since 12Feb 自2月12日起纳入临床诊断

The new SARS-like coronavirus has spread around China since its outbreak in Wuhan - the capital of central China’s Hubei province. As of June 7, 2022, there were 2,785,848 active cases with symptoms in Greater China. The pandemic has caused a significant impact in the country's economy.

Fast-moving epidemic

In Wuhan, over 3.8 thousand deaths were registered in the heart of the outbreak. The total infection number surged on February 12, 2020 in Hubei province. After a change in official methodology for diagnosing and counting cases, thousands of new cases were added to the total figure. There is little knowledge about how the virus that originated from animals transferred to humans. While human-to-human transmission has been confirmed, other transmission routes through aerosol and fecal-oral are also possible. The deaths from the current virus COVID-19 (formally known as 2019-nCoV) has surpassed the toll from the SARS epidemic of 2002 and 2003.

Key moments in the Chinese coronavirus timeline

The doctor in Wuhan, Dr. Li Wenliang, who first warned about the new strain of coronavirus was silenced by the police. It was announced on February 7, 2020 that he died from the effects of the coronavirus infection. His death triggered a national backlash over freedom of speech on Chinese social media. On March 18, 2020, the Chinese government reported no new domestically transmissions for the first time after a series of quarantine and social distancing measures had been implemented. On March 31, 2020, the National Health Commission (NHC) in China started reporting the infection number of symptom-free individuals who tested positive for coronavirus. Before that, asymptomatic cases had not been included in the Chinese official count. China lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country. On April 17, 2020, health authorities in Wuhan revised its death toll, adding some 1,290 fatalities in its total count.

Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.

The difficulties of death figures

This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.

Where are these numbers coming from?

The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.

As of January 1, 2023, the case fatality rate (CFR) of coronavirus COVID-19 ranged at 0.27 percent in China, lower than the global level of 1.01 percent. Health authorities in Wuhan, the Chinese epicenter, revised its death toll on April 17, adding some 1,290 fatalities to its total count. The 50 percent increase of death cases in the city raised the overall CFR in China from 4.06 percent to 5.6 percent. The Chinese Center for Disease Control and Prevention reported that mortality increased with age among infected patients.

Population: Household Registration: Death Rate: Hubei: Wuhan data was reported at 6.820 ‰ in 2022. This records an increase from the previous number of 5.900 ‰ for 2021. Population: Household Registration: Death Rate: Hubei: Wuhan data is updated yearly, averaging 5.720 ‰ from Dec 2007 (Median) to 2022, with 15 observations. The data reached an all-time high of 11.620 ‰ in 2017 and a record low of 4.030 ‰ in 2007. Population: Household Registration: Death Rate: Hubei: Wuhan data remains active status in CEIC and is reported by Wuhan Municipal Bureau of Statistics. The data is categorized under China Premium Database’s Socio-Demographic – Table CN.GE: Population: Prefecture Level City: Household Registration: Natural Growth Rate.

On March 10, 2023, the Johns Hopkins Coronavirus Resource Center ceased collecting and reporting of global COVID-19 data. For updated cases, deaths, and vaccine data please visit the following sources:Global: World Health Organization (WHO)U.S.: U.S. Centers for Disease Control and Prevention (CDC)For more information, visit the Johns Hopkins Coronavirus Resource Center.This feature layer contains the most up-to-date COVID-19 cases and latest trend plot. It covers China, Canada, Australia (at province/state level), and the rest of the world (at country level, represented by either the country centroids or their capitals)and the US at county-level. Data sources: WHO, CDC, ECDC, NHC, DXY, 1point3acres, Worldometers.info, BNO, state and national government health departments, and local media reports. . The China data is automatically updating at least once per hour, and non-China data is updating hourly. This layer is created and maintained by the Center for Systems Science and Engineering (CSSE) at the Johns Hopkins University. This feature layer is supported by Esri Living Atlas team and JHU Data Services. This layer is opened to the public and free to share. Contact us.

The novel coronavirus that originated in the Chinese city Wuhan - the capital of Hubei province - had killed 17,826 people in Greater China. As of June 7, 2022, there were 2,785,848 active cases with symptoms in the region.

How did it spread?

In late December 2019, the health authorities in Wuhan detected several pneumonia cases of unknown cause. Most of these patients had links to the Huanan seafood market. The virus then spread spread rapidly to other provinces when millions of Chinese migrant workers headed home for Chinese New Year celebrations. About five billion people left Wuhan before the start of the travel ban on January 23. Right before Chinese New Year, the central government decided to put Wuhan and other cities in Hubei province on lockdown. With further travel restrictions and cancellations of public celebration events, the number of infections surpassed 80 thousand by the end of February. On March 18, 2020, China reported no new local coronavirus COVID-19 transmissions for the first time after quarantine measures had been implemented. On March 31, 2020, the National Health Commission (NHC) in China announced that it would begin reporting the infection number of symptom-free individuals who tested positive for coronavirus. After no new deaths reported for first time, the Chinese government lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country.

What is COVID-19?

Coronaviruses originate in animals like camels, civets and bats and are usually not transmissible to humans. But when a coronavirus mutates, it can be passed from animals to humans. The new strain of coronavirus COVID-19 is one of the seven known coronaviruses that can infect humans causing fever and respiratory infections. China's National Health Commission has confirmed the virus can be transmitted between humans through direct contact, airborne droplets. Faecal-oral transmission could also be possible. Although the death toll of COVID-19 has surpassed that of SARS, its fatality rate is relatively low compared to other deadly coronavirus, such as SARS and MERS.

According to a medical analysis of 44,672 confirmed COVID-19 cases in China, the overall fatality rate of the novel coronavirus was 2.3 percent. As of February 11, 2020, the fatality rate of patients aged 80 years and older was 14.8 percent.

COVID-19 rate of death, or the known deaths divided by confirmed cases, was over ten percent in Yemen, the only country that has 1,000 or more cases. This according to a calculation that combines coronavirus stats on both deaths and registered cases for 221 different countries. Note that death rates are not the same as the chance of dying from an infection or the number of deaths based on an at-risk population. By April 26, 2022, the virus had infected over 510.2 million people worldwide, and led to a loss of 6.2 million. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.

Where are these numbers coming from?

The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. Note that Statista aims to also provide domestic source material for a more complete picture, and not to just look at one particular source. Examples are these statistics on the confirmed coronavirus cases in Russia or the COVID-19 cases in Italy, both of which are from domestic sources. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.

A word on the flaws of numbers like this

People are right to ask whether these numbers are at all representative or not for several reasons. First, countries worldwide decide differently on who gets tested for the virus, meaning that comparing case numbers or death rates could to some extent be misleading. Germany, for example, started testing relatively early once the country’s first case was confirmed in Bavaria in January 2020, whereas Italy tests for the coronavirus postmortem. Second, not all people go to see (or can see, due to testing capacity) a doctor when they have mild symptoms. Countries like Norway and the Netherlands, for example, recommend people with non-severe symptoms to just stay at home. This means not all cases are known all the time, which could significantly alter the death rate as it is presented here. Third and finally, numbers like this change very frequently depending on how the pandemic spreads or the national healthcare capacity. It is therefore recommended to look at other (freely accessible) content that dives more into specifics, such as the coronavirus testing capacity in India or the number of hospital beds in the UK. Only with additional pieces of information can you get the full picture, something that this statistic in its current state simply cannot provide.

Novel coronavirus (COVID-19) is a new strain of coronavirus first identified in Wuhan, China. Clinical presentation may range from mild-to-moderate illness to pneumonia or severe acute respiratory infection. The COVID-19 pandemic has wider impacts on individuals' health, and their use of healthcare services, than those that occur as the direct result of infection. Reasons for this may include: * Individuals being reluctant to use health services because they do not want to burden the NHS or are anxious about the risk of infection. * The health service delaying preventative and non-urgent care such as some screening services and planned surgery. * Other indirect effects of interventions to control COVID-19, such as mental or physical consequences of distancing measures. This dataset provides information on trend data regarding the wider impact of the pandemic on the number of deaths in Scotland, derived from the National Records of Scotland (NRS) weekly deaths registration data. Data show recent trends in deaths (2020), whether COVID or non-COVID related, and historic trends for comparison (five-year average, 2015-2019). The recent trend data are shown by age group and sex, and the national data are also shown by broad area deprivation category (Scottish Index of Multiple Deprivation, SIMD). This data is also available on the COVID-19 Wider Impact Dashboard. Additional data sources relating to this topic area are provided in the Links section of the Metadata below. Information on COVID-19, including stay at home advice for people who are self-isolating and their households, can be found on NHS Inform. All publications and supporting material to this topic area can be found in the weekly COVID-19 Statistical Report. The date of the next release can be found on our list of forthcoming publications.

Laboratory analyses of dead patients in the last 24 hours of the death.

COVID-19 has become one of the largest epidemics in the world. As of February 11, 2020, the fatality rate of novel coronavirus COVID-19 among male patients ranged around 2.8 percent in China. The figure was based on a medical analysis of 44,672 confirmed cases.

SummaryTotal ever COVID-19 cases and deaths at Maryland congregate living facilities.DescriptionDeprecated as of November 17, 2021.The Outbreak-Associated Cases in Congregate Living data dashboard on coronavirus.maryland.gov was redesigned on 11/17/21 to align with other outbreak reporting. Visit MD COVID-19 Congregate Outbreaks to view Outbreak-Associated Cases in Congregate Living data as reported after 11/17/21.The MD COVID-19 Congregate Cases and Deaths total Summary data layer is the cumulative total of COVID-19 cases and deaths that have occured in nursing homes, assisted living facilities, group homes of 10 or more and state and local facilities. Data are reported to MDH by local health departments, the Department of Public Safety and Correctional Services and the Department of Juvenile Services and are updated once weekly.COVID-19 is a disease caused by a respiratory virus first identified in Wuhan, Hubei Province, China in December 2019. COVID-19 is a new virus that hasn't caused illness in humans before. Worldwide, COVID-19 has resulted in thousands of infections, causing illness and in some cases death. Cases have spread to countries throughout the world, with more cases reported daily. The Maryland Department of Health reports daily on COVID-19 cases by county.

Clinical features of dead patients with COVID-19.

Background: Systemic corticosteroids are now recommended in many treatment guidelines, though supporting evidence is limited to one randomised controlled clinical trial (RECOVERY).

Objective: To identify whether corticosteroids were beneficial to COVID-19 patients.

Methods: 1514 severe and 249 critical hospitalized COVID-19 patients from two medical centers in Wuhan, China. Multivariable Cox models, Cox model with time-varying exposure and propensity score analysis (inverse-probability-of-treatment-weighting (IPTW) and propensity score matching (PSM)) to estimate the association of corticosteroid use with risk of in-hospital mortality in severe and critical cases.

Results: Corticosteroids were administered in 531 (35.1%) severe and 159 (63.9%) critical patients. Compared to non-corticosteroid group, systemic corticosteroid use was not associated with beneficial effect in reducing in-hospital mortality in both severe cases (HR=1.77, 95% CI: 1.08-2.89, p=0.023), and critical cases (HR=2.07, 95% CI: 1.08-3.98, p=0.028). Findings were similar in time-varying Cox analysis. For severe COVID-19 patients at admission, corticosteroid use was not associated with improved or harmful outcome in either PSM or IPTW analysis. For critical COVID-19 patients at admission, results were consistent with multivariable Cox model analysis.

Conclusion: Corticosteroid use was not associated with beneficial effect in reducing in-hospital mortality for severe or critical cases in Wuhan. Absence of the beneficial effect in our study in contrast to that was observed in the RECOVERY clinical trial may be due to biases in observational data, in particular prescription by indication bias, differences in clinical characteristics of patients, choice of corticosteroid used, timing of initiation of treatment and duration of treatment.

SummaryThe cumulative number of confirmed COVID-19 deaths among Maryland residents.DescriptionThe MD COVID-19 - Total Confirmed Deaths Statewide data layer is a collection of the statewide confirmed COVID-19 related deaths that have been reported each day by the Vital Statistics Administration. A death is classified as confirmed if the person had a laboratory-confirmed positive COVID-19 test result. Some data on deaths may be unavailable due to the time lag between the death, typically reported by a hospital or other facility, and the submission of the complete death certificate. Probable deaths are available from the MD COVID-19 - Total Probable Deaths Statewide data layer. Update 5/27/21: The Maryland Department of Health (MDH) Vital Statistics Administration (VSA) revised the state’s COVID-19 data to include deaths that were not properly classified by medical certifiers over the past year. VSA identified these deaths as COVID-19 deaths through an information reconciliation process utilizing other sources of data. Learn more: https://health.maryland.gov/newsroom/Pages/Maryland-Department-of-Health-Vital-Statistics-Administration-issues-revision-of-COVID-19-death-data.aspxCOVID-19 is a disease caused by a respiratory virus first identified in Wuhan, Hubei Province, China in December 2019. COVID-19 is a new virus that hasn't caused illness in humans before. Worldwide, COVID-19 has resulted in thousands of infections, causing illness and in some cases death. Cases have spread to countries throughout the world, with more cases reported daily. The Maryland Department of Health reports daily on COVID-19 cases by county.

This statistic shows the fatality rate of COVID-19 by age groups in France. As of February 15, 2020, the fatality rate of patients aged 75 years and older was 10.3 percent. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Purpose: Computed tomography (CT) characteristics associated with critical outcomes of patients with coronavirus disease 2019 (COVID-19) have been reported. However, CT risk factors for mortality have not been directly reported. We aim to determine the CT-based quantitative predictors for COVID-19 mortality.Methods: In this retrospective study, laboratory-confirmed COVID-19 patients at Wuhan Central Hospital between December 9, 2019, and March 19, 2020, were included. A novel prognostic biomarker, V-HU score, depicting the volume (V) of total pneumonia infection and the average Hounsfield unit (HU) of consolidation areas was automatically quantified from CT by an artificial intelligence (AI) system. Cox proportional hazards models were used to investigate risk factors for mortality.Results: The study included 238 patients (women 136/238, 57%; median age, 65 years, IQR 51–74 years), 126 of whom were survivors. The V-HU score was an independent predictor (hazard ratio [HR] 2.78, 95% confidence interval [CI] 1.50–5.17; p = 0.001) after adjusting for several COVID-19 prognostic indicators significant in univariable analysis. The prognostic performance of the model containing clinical and outpatient laboratory factors was improved by integrating the V-HU score (c-index: 0.695 vs. 0.728; p < 0.001). Older patients (age ≥ 65 years; HR 3.56, 95% CI 1.64–7.71; p < 0.001) and younger patients (age < 65 years; HR 4.60, 95% CI 1.92–10.99; p < 0.001) could be further risk-stratified by the V-HU score.Conclusions: A combination of an increased volume of total pneumonia infection and high HU value of consolidation areas showed a strong correlation to COVID-19 mortality, as determined by AI quantified CT.

After the outbreak of the coronavirus (COVID-19) in Italy, many people died after contracting the infection. As of May 2023, the mortality rate for female patients in Italy was 0.6 percent, the corresponding figure for male patients was 0.9 percent. The chart shows how this gap was recorded among all age groups.

Italy's death toll was one of the most tragic in the world. In the last months, however, the country saw the end to this terrible situation: as of May 2023, roughly 84.7 percent of the total Italian population was fully vaccinated.

The virus originated in Wuhan, a Chinese city populated by millions and located in the province of Hubei. More statistics and facts about the virus in Italy are available here. For a global overview visit Statista's webpage exclusively dedicated to coronavirus, its development, and its impact.